Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2740-2017Class II

PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number...

Flowonix Medical Inc / initiated 2017-05-22 / Terminated / root cause: design

Flowonix Medical, Inc. began a recall of PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc... on . FDA classified it as Class II and gives the reason as "Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design...". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-2740-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Flowonix Medical Inc
Product
PROMETRA II Programmable Infusion Pump, Implantable Infusion Pump, Catalog Number/REF 13827, Part Number PL-31790-02. Manufactured by: Flowonix Medical Inc., --- The correction involves the labeling of the device plus the following Prometra II pump labeling is also being revised: Intrathecal Catheter IFU, REF 11823, PL-22790-02; Catheter Revision Kit IFU, REF 11 830, PL-21798-02; Refill Kit IFU, REF 11825, PL-21794-00; Prometra II Patient Implant Card (Permanent) PL-32300-01; Prometra II Patient Implant Card (Temporary): PL-32375-01; Prometra II Patient Guide: PL-31912-01. The Prometra Programmable Infusion Pump System is indicated for intrathecal infusion of Infumorph (preservative-free morphine sulfate sterile solution) or preservative-free sterile 0.9% saline solution (sodium chloride injection, USP).
Product code
LKK Pump, Infusion, Implanted, Programmable
Reason for recall
Flowonix Medical received a report of a patient implanted with the Prometra II Programmable Pump who may have received a fatal drug overdose during an MRI procedure. The Prometra II pump has an FDA-approved design feature intended to permit safe exposure to an MRI without removing drug from the reservoir.
Root cause tag
design
FDA root cause
Under Investigation by firm
Action
Flowonix sent an URGENT MEDICAL DEVICE CORRECTION Letter and Response Forms dated May 22, 2017, with updated instructions were sent via UPS 2nd Day Air on May 25, 2017 to healthcare professionals: physicians and MRI facilities and technicians. The documents will also be available at www.flowonix.com. A Correction Letter will also be sent to patients to inform them of the labeling changes. For further questions, please call (973) 426-9229.
Quantity in commerce
US: 2204 units
Distribution
Nationwide Distribution
Product codes and lots
All

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2740-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2740-2017Class IITerminatedVoluntary: Firm initiated